AUNTEA JENNY (02589) announces a profit for the year ending in 2025 is expected to be between 4.95 billion and 5.25 billion, representing an increase of approximately 50% to 60% compared to the previous year.
Auntie on the Bund (02589) announces that the group is expected to achieve a profit after tax of approximately RMB 4.95 billion to RMB 5.25 billion for the year ending December 31, 2025 (reporting period), an increase of approximately 50% to 60% compared to RMB 3.29 billion in the same period last year. The group is expected to achieve an adjusted profit after tax (non-International Financial Reporting Standards measurement) of approximately RMB 5.6 billion to RMB 5.9 billion for the reporting period, an increase of approximately 34% to 41% compared to last year's adjusted profit after tax of RMB 4.18 billion.
AUNTEA JENNY (02589) announced that the Group is expected to achieve a net profit ranging from approximately RMB 4.95 billion to RMB 5.25 billion for the year ending December 31, 2025 (reporting period), which represents an increase of about 50% to 60% compared to the net profit of RMB 3.29 billion in the same period last year. The Group is expected to achieve an adjusted net profit (measured under non-international financial reporting standards) of approximately RMB 5.6 billion to RMB 5.9 billion, which is an increase of about 34% to 41% from the adjusted net profit of RMB 4.18 billion in the same period last year.
The board of directors believes that the expected increase in net profit and adjusted net profit is mainly due to the Group's commitment to a multi-brand development strategy, focusing on providing consumers with high-quality products and services, relying on the omni-channel operating model of Wuxi Online Offline Communication Information Technology Co., Ltd. By continuously launching new products, enriching consumer scenarios, and better meeting the diverse needs of consumers, the Group has achieved continuous improvement in store operation quality and continuous expansion of the store network, effectively driving the growth of revenue. At the same time, the Group focuses on optimizing operational efficiency, continuously promoting cost reduction and efficiency improvement efforts, and the improvement in operation efficiency across the entire value chain further drives the overall profitability.
Related Articles

Haisco Pharmaceutical Group (002653.SZ): Innovative drug HSK31679 tablet included in breakthrough therapy program.

Yinbang Clad Material (300337.SZ) is planning to register and issue medium-term notes.

HK Stock Market Move | NATURAL FOOD IH(01837) continues to rise by over 5%, offline channel business significantly grows, with annual net profit increasing by approximately 40% compared to the previous year.
Haisco Pharmaceutical Group (002653.SZ): Innovative drug HSK31679 tablet included in breakthrough therapy program.

Yinbang Clad Material (300337.SZ) is planning to register and issue medium-term notes.

HK Stock Market Move | NATURAL FOOD IH(01837) continues to rise by over 5%, offline channel business significantly grows, with annual net profit increasing by approximately 40% compared to the previous year.

RECOMMEND

“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
11/03/2026

Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
11/03/2026

U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
11/03/2026


